Induction of potent NK cell-dependent anti-myeloma cytotoxic T cells in response to combined mapatumumab and bortezomib. [electronic resource]
- Oncoimmunology Sep 2015
- e1038011 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't